An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Status:
Completed

Trial end date:
2006-08-01

Target enrollment:

Participant gender:

A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.

Phase 2

Pfizer